Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-16

Clinical Trial Update: Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Triapine in combination with chemotherapy and radiation for IB2-IVA cervical or vaginal cancer; results posted and the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triapine (Triapine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-10-16